Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bartholomew P Roland

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Personalized Medicine|November 27, 2021
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT ProgramMichelle Liu, Sara L Van Driest, Cindy L Vnencak-Jones, et al.
Current Biology : CB|November 21, 2023
Predatory fireflies and their toxic firefly prey have evolved distinct toxin resistance strategiesLu Yang, Flora Borne, Anja Betz, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Predatory fireflies and their toxic firefly prey have evolved distinct toxin resistance strategiesLu Yang, Flora Borne, Anja Betz, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Triosephosphate isomerase I170V alters catalytic site, enhances stability and induces pathology in a Drosophila model of TPI deficiencyBartholomew P Roland, Christopher G Amrich, Charles J Kammerer, et al.
Elife|August 28, 2019
Adaptive substitutions underlying cardiac glycoside insensitivity in insects exhibit epistasis in vivoAndrew M Taverner, Lu Yang, Zachary J Barile, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 11, 2019
Missense variant in TPI1 (Arg189Gln) causes neurologic deficits through structural changes in the triosephosphate isomerase catalytic site and reduced enzyme levels in vivoBartholomew P Roland, Kristen R Richards, Stacy L Hrizo, et al.
ACS Chemical Neuroscience|June 6, 2026
Discovery of VU6053371/BI03738809: A First-in-Class Selective and CNS-Penetrant mGlu<sub>3</sub> Positive Allosteric Modulator (PAM) with Efficacy in a Preclinical Cognition ModelCaleb A Jones, Renn A Duncan, Kristen M Gilliland, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Personalized Medicine|November 27, 2021
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT ProgramMichelle Liu, Sara L Van Driest, Cindy L Vnencak-Jones, et al.
Current Biology : CB|November 21, 2023
Predatory fireflies and their toxic firefly prey have evolved distinct toxin resistance strategiesLu Yang, Flora Borne, Anja Betz, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Predatory fireflies and their toxic firefly prey have evolved distinct toxin resistance strategiesLu Yang, Flora Borne, Anja Betz, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Triosephosphate isomerase I170V alters catalytic site, enhances stability and induces pathology in a Drosophila model of TPI deficiencyBartholomew P Roland, Christopher G Amrich, Charles J Kammerer, et al.
Elife|August 28, 2019
Adaptive substitutions underlying cardiac glycoside insensitivity in insects exhibit epistasis in vivoAndrew M Taverner, Lu Yang, Zachary J Barile, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 11, 2019
Missense variant in TPI1 (Arg189Gln) causes neurologic deficits through structural changes in the triosephosphate isomerase catalytic site and reduced enzyme levels in vivoBartholomew P Roland, Kristen R Richards, Stacy L Hrizo, et al.
ACS Chemical Neuroscience|June 6, 2026
Discovery of VU6053371/BI03738809: A First-in-Class Selective and CNS-Penetrant mGlu<sub>3</sub> Positive Allosteric Modulator (PAM) with Efficacy in a Preclinical Cognition ModelCaleb A Jones, Renn A Duncan, Kristen M Gilliland, et al.
Pageof 2